PINK:LTUS

Lotus Pharmaceuticals Stock Insider Trading

Financial Services > Shell Companies

Buy LTUS

*Your capital is at risk

$0.0044

+0 (+0%)

At Close: Jun 23, 2026

Lotus Pharmaceuticals Stock Insider Power

Based on the 16 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 306.8K and sold 133.4K LTUS shares in the last 16 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 16 transactions)	0
● Buy	306.8K shares
● Sell	133.4K shares
75% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Aug 21, 2007 Buy	Common Stock J-Other	Wasserman Adam C CFO	C-Suite Officer	50 000 Value: $27.5K
Aug 21, 2007 Buy	Common Stock J-Other	Wasserman Adam C CFO	C-Suite Officer	50 000 Value: $27.5K
May 31, 2007 Buy	Common Stock J-Other	Wasserman Adam C CFO	C-Suite Officer	44 200 Value: $44.2K
May 31, 2007 Buy	Common Stock J-Other	Wasserman Adam C CFO	C-Suite Officer	44 200 Value: $44.2K
Jan 06, 2004 Sell	Common stock J-Other	Nierenberg David	Director	25 000 Value: $0
Jan 06, 2004 Sell	Common stock J-Other	Nierenberg David	Director	25 000 Value: $0
Aug 25, 2003 Buy	Common stock J-Other	Nierenberg David	Director	41 700 Value: $0
Aug 25, 2003 Sell	Common stock J-Other	Nierenberg David	Director	41 700 Value: $0
Aug 25, 2003 Buy	Common stock J-Other	Nierenberg David	Director	41 700 Value: $0
Aug 25, 2003 Sell	Common stock J-Other	Nierenberg David	Director	41 700 Value: $0
May 01, 2003 Buy	Common Stock J-Other	Nierenberg David	Director	0 Value: $0
May 01, 2003 Buy	Common Stock J-Other	Nierenberg David	Director	0 Value: $0
Nov 22, 2002 Buy	Option (right to acquire) P-Purchase	Nierenberg David	Director	7 500 Value: $84.6K
Nov 22, 2002 Buy	Option (right to acquire) P-Purchase	Nierenberg David	Director	7 500 Value: $84.6K
Oct 18, 2001 Buy	Option (right to acquire) P-Purchase	Nierenberg David	Director	10 000 Value: $67.8K
Oct 18, 2001 Buy	Option (right to acquire) P-Purchase	Nierenberg David	Director	10 000 Value: $67.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT LOTUS PHARMACEUTICALS, INC.

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee....

Read Full Profile Here